HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

PPARalpha ligand WY14643 reduced acute rejection after rat lung transplantation with the upregulation of IL-4, IL-10 and TGFbeta mRNA expression.

AbstractBACKGROUND:
The peroxisome proliferators-activated receptor-alpha (PPARalpha) is important in lipid metabolism and regulation of inflammation. Recent studies have demonstrated the immunoregulatory effects of PPARalpha. This investigated the immunosuppressive effects of PPARalpha using its ligand, WY14643, on acute lung allograft rejection in a rat model and its mechanism of action.
METHOD:
The left lungs were transplanted orthotopically from Brown-Norway donors to F344 recipients. The recipients were then divided into control and WY14643 treatment groups. The allograft rejection was evaluated by daily chest X-ray imaging and was evaluated histologically on Day 7 after transplantation. The cytokine messenger RNA (mRNA) expression at Days 3 and 5 were also evaluated in allografts and recipient spleens.
RESULTS:
The radiologic and histologic findings indicated that treatment with the WY14643 reduced acute allograft rejection. WY14643 also significantly extended the allograft survival time. This amelioration of acute rejection by WY14643 was also associated with up-regulated interleukin (IL)-4, IL-10, and transforming growth factor-beta (TGFbeta) mRNA expression in the lung allografts and spleens.
CONCLUSION:
This study demonstrated that the administration of the PPARa ligand, WY14643, ameliorates acute lung allograft rejection in rats. Treatment with WY14643 reduced histopathologic scores, prolonged graft survival, and up-regulated the expression of anti-inflammatory cytokine IL-4, IL-10, and TGFbeta mRNA compared with the control.
AuthorsJun Yanagisawa, Takeshi Shiraishi, Akinori Iwasaki, Shinichi Maekawa, Takao Higuchi, Masafumi Hiratuka, Toshihiro Tanaka, Hirotomo Shibaguchi, Masahide Kuroki, Takayuki Shirakusa
JournalThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation (J Heart Lung Transplant) Vol. 28 Issue 11 Pg. 1172-9 (Nov 2009) ISSN: 1557-3117 [Electronic] United States
PMID19782605 (Publication Type: Journal Article)
Chemical References
  • PPAR alpha
  • Pyrimidines
  • RNA, Messenger
  • Transforming Growth Factor beta
  • Interleukin-10
  • Interleukin-4
  • pirinixic acid
Topics
  • Animals
  • Graft Rejection (pathology, prevention & control)
  • Interleukin-10 (genetics)
  • Interleukin-4 (genetics)
  • Lung Transplantation (pathology)
  • PPAR alpha (physiology)
  • Pyrimidines (therapeutic use)
  • RNA, Messenger (genetics)
  • Rats
  • Rats, Inbred BN
  • Rats, Inbred F344
  • Transforming Growth Factor beta (genetics)
  • Up-Regulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: